CORDIS - EU research results
CORDIS

DESIGN STUDY FOR A EUROPEAN VACCINE INFRASTRUCTURE

Project description

European infrastructure for the development of human and veterinary vaccines

The EU-funded TRANSVAC-DS project aims to further explore and advance the establishment of a Pan-European vaccine infrastructure, based on the achievements of the previous TRANSVAC1/2 projects which since the beginning in 2009 are providing significant support to the development of human and veterinary prophylactic and therapeutic vaccines. The TRANSVAC-DS consortium consists of 25 partners from ten EU Member States and Associated Countries and includes leading organisations from the European vaccine research and development field. The main output of TRANSVAC-DS will be a conceptual design report, including a five-year business plan together with an implementation plan, that will describe in detail the maturity of the concept and be the basis for the establishment of a permanent and sustainable vaccine infrastructure.

Objective

The TRANSVAC-DS project further builds on the outstanding success of EC-funded projects:TRANSVAC1 and TRANSVAC2 and proposes the establishment of a truly sustainable European vaccine infrastructure, which will build upon the lessons learned, activities and achievements of the TRANSVAC1/2 projects.
Two infrastructure projects -TRANSVAC1 and TRANSVAC2- have been funded by the European Commission which -through the provision of state-of-the-art scientific-technical vaccine development services, technical training, and innovative vaccine research and development- have provided very significant support to European vaccine researchers and developers. Support has been, and is being provided to the development of human and veterinary prophylactic and therapeutic vaccines.
The twenty-five partners in the TRANSVAC-DS consortium that will contribute to the outcome of the project represent ten EU Member States and Associated Countries and include leading organisations from the European vaccine R&D field.
The main output of TRANSVAC-DS will be a conceptual design report that will describe in detail the maturity of the concept and be the basis for the establishment of a permanent and sustainable vaccine infrastructure of direct relevance to and benefit for Europe and further afield. As part of the design report, a five-year business plan will be delivered together with an implementation plan that will guide the further establishment of a sustainable European vaccine infrastructure.

Call for proposal

H2020-INFRADEV-2018-2020

See other projects for this call

Sub call

H2020-INFRADEV-2019-3

Coordinator

EUROPEAN VACCINE INITIATIVE E.V
Net EU contribution
€ 989 025,00
Address
VOSSSTRASSE 2, GEB. 4040
69115 Heidelberg
Germany

See on map

Region
Baden-Württemberg Karlsruhe Heidelberg, Stadtkreis
Activity type
Research Organisations
Links
Total cost
€ 989 025,00

Participants (27)